Huron Consulting Group’s (HURN) “Outperform” Rating Reiterated at William Blair

William Blair reissued their outperform rating on shares of Huron Consulting Group (NASDAQ:HURN) in a research report released on Wednesday morning,RTT News reports. William Blair also issued estimates for Huron Consulting Group’s Q1 2025 earnings at $1.17 EPS, Q2 2025 earnings at $1.83 EPS, Q3 2025 earnings at $2.10 EPS, Q4 2025 earnings at $1.99 EPS, FY2025 earnings at $7.09 EPS, Q1 2026 earnings at $1.34 EPS, Q2 2026 earnings at $2.08 EPS, Q3 2026 earnings at $2.34 EPS, Q4 2026 earnings at $2.24 EPS and FY2026 earnings at $8.00 EPS.

Several other equities analysts also recently issued reports on HURN. Wedbush started coverage on shares of Huron Consulting Group in a research note on Monday, February 3rd. They set an “outperform” rating on the stock. StockNews.com raised shares of Huron Consulting Group from a “hold” rating to a “buy” rating in a research note on Thursday, October 31st. Benchmark increased their price target on shares of Huron Consulting Group from $140.00 to $165.00 and gave the stock a “buy” rating in a research note on Wednesday. Truist Financial reaffirmed a “buy” rating and set a $165.00 price target (up previously from $140.00) on shares of Huron Consulting Group in a research note on Wednesday. Finally, Barrington Research increased their price target on shares of Huron Consulting Group from $137.00 to $142.00 and gave the stock an “outperform” rating in a research note on Monday, November 4th. Six investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, Huron Consulting Group currently has an average rating of “Buy” and a consensus target price of $151.75.

Huron Consulting Group Stock Performance

Shares of HURN opened at $152.46 on Wednesday. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.61 and a current ratio of 1.61. The company has a market capitalization of $2.70 billion, a price-to-earnings ratio of 33.14 and a beta of 0.59. The company’s 50 day simple moving average is $126.92 and its 200 day simple moving average is $117.81. Huron Consulting Group has a 1 year low of $84.26 and a 1 year high of $153.77.

Huron Consulting Group (NASDAQ:HURN) last announced its quarterly earnings data on Tuesday, February 25th. The business services provider reported $1.90 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.52 by $0.38. The business had revenue of $399.31 million for the quarter, compared to the consensus estimate of $380.62 million. Huron Consulting Group had a net margin of 5.80% and a return on equity of 21.51%. On average, sell-side analysts predict that Huron Consulting Group will post 6.1 EPS for the current year.

Insider Transactions at Huron Consulting Group

In other news, Director H Eugene Lockhart sold 12,500 shares of the stock in a transaction on Wednesday, February 26th. The shares were sold at an average price of $150.00, for a total value of $1,875,000.00. Following the completion of the sale, the director now owns 12,172 shares of the company’s stock, valued at $1,825,800. This represents a 50.66 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director James H. Roth sold 2,000 shares of the stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $123.70, for a total transaction of $247,400.00. Following the completion of the sale, the director now directly owns 52,825 shares of the company’s stock, valued at $6,534,452.50. The trade was a 3.65 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 21,084 shares of company stock valued at $2,942,539 over the last 90 days. Corporate insiders own 2.02% of the company’s stock.

Institutional Investors Weigh In On Huron Consulting Group

A number of large investors have recently added to or reduced their stakes in HURN. Dakota Wealth Management increased its stake in Huron Consulting Group by 4.0% during the 4th quarter. Dakota Wealth Management now owns 2,250 shares of the business services provider’s stock worth $280,000 after buying an additional 87 shares during the period. Assetmark Inc. increased its stake in Huron Consulting Group by 7.0% during the 3rd quarter. Assetmark Inc. now owns 1,373 shares of the business services provider’s stock worth $149,000 after buying an additional 90 shares during the period. Summit Investment Advisors Inc. increased its stake in Huron Consulting Group by 5.5% during the 4th quarter. Summit Investment Advisors Inc. now owns 1,838 shares of the business services provider’s stock worth $228,000 after buying an additional 96 shares during the period. Andina Capital Management LLC increased its stake in Huron Consulting Group by 3.4% during the 4th quarter. Andina Capital Management LLC now owns 3,296 shares of the business services provider’s stock worth $410,000 after buying an additional 107 shares during the period. Finally, Martingale Asset Management L P increased its stake in Huron Consulting Group by 0.5% during the 3rd quarter. Martingale Asset Management L P now owns 20,479 shares of the business services provider’s stock worth $2,226,000 after buying an additional 110 shares during the period. 93.90% of the stock is owned by institutional investors and hedge funds.

Huron Consulting Group Company Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.